Lv1
50 积分 2022-09-20 加入
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
4个月前
已完结
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
5个月前
已完结
Guideline of guidelines: non‐muscle‐invasive bladder cancer
5个月前
已完结
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline
9个月前
已完结
Impaired Dynamic Cerebral Autoregulation as a Predictor for Cerebral Hyperperfusion After Carotid Endarterectomy: A Prospective Observational Study
1年前
已完结
Impaired Dynamic Cerebral Autoregulation in Patients With Cerebral Venous Sinus Thrombosis: Evaluation Using Transcranial Doppler and Silent Reading Stimulation
1年前
已完结
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer
1年前
已完结
Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy
1年前
已完结
Gut microbiota and autoimmune neurologic disorders: a two-sample bidirectional Mendelian randomization study
1年前
已完结
Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases
1年前
已完结
皖公网安备34019202002308
